Page 10«..9101112..2030..»

Varian (VAR) Rides on Oncology and Proton Therapy Businesses – Nasdaq

Posted: August 17, 2017 at 5:50 am

On Aug 14, we issued an updated research report on Palo Alto, CA-based Varian Medical Systems Inc.VAR . The company is the world’s leading provider of radiotherapy, radiosurgery, proton therapy and brachytherapy for treating cancer and other medical conditions.

Varian Medical had an unimpressive run on the bourse over the last one month, trading below the industry in terms of price performance. A glimpse at the share price movement reveals that Varian Medical’s shares have lost 6.4%, comparing unfavorably with 3.0% decline of the industry.

Looking forward, Varian Medical’s oncology and Proton therapy business’ growth prospects remain impressive. The company is addressing both the tier 1 and mid-tier markets through its Edge, Truebeam and VitalBeam, Halcyon products. The company is winning contracts, not only in the Americas but also in the emerging international markets, which is a huge positive. We believe that China and Africa present significant top-line growth opportunity in the near term. The company is opening new offices in Africa and the Middle East, which will provide growth opportunities in the region.

Varian Medical operates in a technology-driven environment where success depends on innovation and frequent product updates. The company has been successful on the R&D front as evident from year-over-year growth in its top line. The company has approximately $1 billion revenue opportunity from its various Oncology and Imaging Component products over the next five years. The varied offerings include TrueBeam and Edge platforms, InSightive Analytics, Qumulate QA and RapidPlan knowledge-based treatment planning. We believe that Varian Medical’s innovative product pipeline will continue to drive growth over the long term.

Apart from enjoying a dominant market share in conventional radiotherapy, we believe that proton therapy also holds significant promise for Varian Medical. This is because ProBeam Compact proton therapy system is superior to other external beam radiotherapies in precisely locating cancerous tumors and causes lesser side effects to surrounding tissues. Proton therapy system uses the same interface used by the company in its TrueBeam platform.

Finally the company’s strong overseas presence is expected to enable it to leverage this opportunity in emerging markets. In line with growing demand for cancer treatment in overseas markets, Varian Medical’s sales, in Europe, Africa and particularly Asia, are growing at a faster rate than in the domestic market.

On the flip side, unfavorable currency translation continues to be a major dampener for the stock. Management fears that further strengthening of the dollar against foreign currencies will lead to deteriorating operating results.

Intense competition as well as the possibility that Varian Medical’s new test might not generate meaningful profits to outweigh the costs associated with its development, continues to raise concern.

Zacks Rank and Key Picks

Varian Medical carries a Zacks Rank #3 (Hold). Some better-ranked medical stocks are Edwards Lifesciences Corp. EW , Steris Plc STE and Align Technology, Inc. ALGN . Edwards Lifesciences and Align Technology sport a Zacks Rank #1 (Strong Buy), while Steris carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here .

Edwards Lifesciences has a positive earnings surprise of 10.75% over the trailing four quarters. The stock has gained around 0.9% over the last three months.

Align Technology has a long-term expected earnings growth rate of 26.6%. The stock has rallied roughly 25.4% over the last three months.

Steris has a positive earnings surprise of 0.78% over two of the trailing four quarters. The stock has gained 13.1% over the last three months.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it’s predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce “the world’s first trillionaires,” but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks’ 3 Best Stocks to Play This Trend >>

Varian Medical Systems, Inc. (VAR): Free Stock Analysis Report

Edwards Lifesciences Corporation (EW): Free Stock Analysis Report

Align Technology, Inc. (ALGN): Free Stock Analysis Report

STERIS PLC (STE): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

See more here:
Varian (VAR) Rides on Oncology and Proton Therapy Businesses – Nasdaq

Posted in Oncology | Comments Off on Varian (VAR) Rides on Oncology and Proton Therapy Businesses – Nasdaq

Clovis Oncology, Inc. (CLVS): What’s the Story? – StockNewsJournal

Posted: at 5:50 am

Clovis Oncology, Inc. (CLVS) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $71.88, up from yesterdays close by 3.36%. Given the stocks recent action, it seemed like a good time to take a closer look at the companys recent data.

Fundamental Analysis

Does this stock stack up well when compared to its peers in the industry space? Lets take a look. Clovis Oncology, Inc. (CLVS) currently trades with a market capitalization of $3.44 Billion.

The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For CLVS, the company currently has $491.79 Million of cash on the books. You can get a sense of how sustainable that is by a levered free cash flow of $-267.33 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $-1.17 on a per share basis this quarter. Perhaps, that suggests something about why 85.51% of the outstanding share supply is held by institutional investors.

Technical Analysis

Its important to check the technicals to get a sense of how CLVS has been acting. Looking at the stocks movement on the chart, Clovis Oncology, Inc. recorded a 52-week high of $99.45. It is now trading 27.57% off that level. The stock is trading $82.06 its 50-day moving average by 10.18%. The stock carved out a 52-week low down at $16.58.

In recent action, Clovis Oncology, Inc. (CLVS) has made a move of -15.43% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is outperforming the S&P 500 by 293.79, and its gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 16.45% with $47.31 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of CLVS.

Read the rest here:
Clovis Oncology, Inc. (CLVS): What’s the Story? – StockNewsJournal

Posted in Oncology | Comments Off on Clovis Oncology, Inc. (CLVS): What’s the Story? – StockNewsJournal

Cancer Research UK and Newcastle University extend successful multi-project drug discovery alliance with Astex … – Cancer Research UK

Posted: at 5:49 am

Cancer Research UK* and Newcastle Universityannounce a three year extension to their major strategic drug discovery alliance with Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics.

The alliance, which was formed five years ago, brings together world-leading researchers in structural and cellular biology, and medicinal chemistry with the innovative fragment-based small molecule drug discovery and development capabilities of Astex.

The researchers at the Cancer Research UK Drug Discovery Programme at the Northern Institute for Cancer Research (NICR), Newcastle University, will work to identify and develop new cancer drugs and associated biomarkers.

The existing portfolio of research consists of multiple projects spanning target validation and early stage medicinal chemistry, with projects progressing towards the more advanced stages of preclinical development.

The new agreement also includes provisions for further extension of the alliance towards the end of the new three year term.

Astex retains the right to an exclusive worldwide licence to take the most promising projects forward into pre-clinical and clinical drug development. In return, Cancer Research UK and Newcastle University are eligible to receive milestone and royalty payments on any compounds that Astex takes into clinical development and successfully commercialises.

Dr Iain Foulkes, Cancer Research UKs executive director of research and innovation, said: Were delighted to extend this major collaboration which accelerates the development of Cancer Research UKs world class work into new treatments for patients.

Promising new compounds resulting from this partnership are now progressing towards the next stage of development. Multi-project alliances like this are powerful engines for innovation and drug discovery and this announcement underlines Cancer Research UKs exceptional track record of bringing these together successfully.

Steve Wedge, Professor of Stratified Cancer Medicine Discovery at Newcastle University, said: The innovative academic-industry collaborative model pioneered with Astex has been a genuine success and we are thrilled to be able to continue working in partnership on our drug discovery research.

The alliance benefits significantly from complementary expertise and provides a route to progress promising novel therapies towards clinical use.

Dr Harren Jhoti, President and Chief Executive Officer of Astex, said: The extension of our agreement with Newcastle and Cancer Research UK underlines the success of our existing alliance and the importance we place on collaboration with world leading academic research groups to strengthen our efforts to discover new treatments for patients.

We look forward to continuing our important work and to continued success in bringing new compounds into development.

View post:
Cancer Research UK and Newcastle University extend successful multi-project drug discovery alliance with Astex … – Cancer Research UK

Posted in Cancer Research | Comments Off on Cancer Research UK and Newcastle University extend successful multi-project drug discovery alliance with Astex … – Cancer Research UK

Running Marvel 5K donates to cancer research, local school – The Star Democrat

Posted: at 5:49 am

EASTON The second annual Running Marvel 5K Run and Walk was held on July 3 on the Easton High School track and Eastons Rails-to-Trails. Proceeds from the charity event were donated to cancer research and for the establishment of a scholarship at Easton High School.

The event is a memorial celebration of the life of Don Marvel, a lifelong resident of Talbot County and a teacher and coach at Easton High School for 32 years. An avid runner, Marvel competed nationally in marathons and ultra-distance races. He died in July 2015 after a four-year battle with kidney cancer.

This years $1,500 scholarship was awarded to 2017 graduating Easton High School senior Quinn Jennings, the captain of EHSs varsity track and field team. Additionally, a donation to support kidney cancer immunotherapy research in the amount of $7,000was presented on July 26 to Ellen Roberts, senior associate director of development for the Johns Hopkins Kimmel Cancer Center.

We are grateful for the community support we receive for the Running Marvel 5K, said event organizer Murray Sarubin, Through the generosity of our sponsors and the runners and walkers who participate.

The third annual Running Marvel 5K will take place in June 2018.

View original post here:
Running Marvel 5K donates to cancer research, local school – The Star Democrat

Posted in Cancer Research | Comments Off on Running Marvel 5K donates to cancer research, local school – The Star Democrat

Cancer Research UK named as charity partner of OPAP Limassol Marathon GSO – UK Fundraising

Posted: at 5:49 am

Cancer Research UK has been named as charity partner for the 2018 OPAP Limassol Marathon GSO, which takes place on Sunday 18th March.

The OPAP Limassol Marathon GSO offers six races over two days, Saturday 17th and Sunday 18th March, with a 21km course along the Mediterranean coastline, from the seafront at Molos to the new port, the old harbour and the ancient ruins of the Royal City of Amathus. The other races are a half marathon, a 10K route, a 5K city route, a 5K corporate race, and a 1K youth race.

All money raised at the OPAP Limassol Marathon GSO will go to support Cancer Research UKs work. Entries are already open: early bird entrants receive a 40% discount until 31stOctober, with fees as follows: Marathon 36, Half Marathon 27, Petrolina 10K Energy Race 18, 5K City Race 18.

Claudia Ratcliffe, Sports Partnership Manager at Cancer Research UK, said:

Cancer Research UK is thrilled to be a charity partner for the 2018 OPAP Limassol Marathon GSO, and it is very exciting to be involved in such a big international event that is known for its friendly welcoming atmosphere. We hope that many runners will be inspired to run for Cancer Research UK. We will be there every step of the way to help them achieve their goals, from training plans and practical fundraising ideas to being out in full force on the day to cheer them on! We are looking forward to welcoming runners of all abilities to Team Cancer Research UK.

227total views, 227views today

See the rest here:
Cancer Research UK named as charity partner of OPAP Limassol Marathon GSO – UK Fundraising

Posted in Cancer Research | Comments Off on Cancer Research UK named as charity partner of OPAP Limassol Marathon GSO – UK Fundraising

Jordan softball donates funds to American Cancer Society – Columbus Ledger-Enquirer

Posted: at 5:49 am

After fundraising via a Hit-A-Thon and raffles in July, the Jordan softball squad had the chance to give back on Aug. 10.

The Red Jackets made their home opener against Carver a special one thanks to the pre-game festivities. Prior to the first pitch, the team presented a $1,500 check to the American Cancer Society. Denise Dowdy was on hand to accept the check on behalf of the ACS.

Donations are how the American Cancer Society is able to make cancer research a reality, Dowdy said. When we can involve youth and schools, it makes the donation a little different. These ladies have worked hard to make an impact on the fight against cancer. We are grateful for this donation.

Senior center fielder and shortstop Alex Garcia said the chance to help fund the fight against cancer meant a great deal to herself and her Red Jackets teammates.

A lot of us have been affected by cancer, whether it was friends or family members, Garcia said. Giving the money could potentially help with the next persons treatment. Its good to give back to a community that sees a lot of negative.

Jordan head coach John Dimitri explained the second edition of the fundraiser had a lot of support from the Columbus community and the Jordan alumni. In order to reach the $1,500 mark, the team members sold 300 raffle tickets, with $5 from each ticket going toward the ACS donation.

The buy-in from the community helped Jordan hit the $1500 mark for the second consecutive year.

We had a good supporting cast show up to where the girls were able to meet some of the past alumni and have a good day with the donation and the raising of the money, Dimitri said of the July 15 event. We look at these things like its not just about softball; its about who we can help and how we can help. You never know who needs help or when youre going to need help. If we can teach the girls the meaning of helping others for a bigger cause, thats what were trying to do.

The fundraiser was a two-prong project, with funds going toward the teams needs as well as the ACS. Seeing so many donate to the causes did not go unnoticed to the Jordan players, including Garcia.

Its always good to know we have people behind us as we help the community, Garcia said. Everything we do, we try to do for our community. We try to give our alumni association a sense of pride in us as well as giving back to Columbus.

Dimitri said the plan is to repeat the fundraiser again next year. Of course, Dimitri wants to push the goal up for the Red Jackets, with the hope being to donate $3,000.

Regardless of the final count, Dimitri said he was just pleased to help with a cause that means so much to so many.

Anytime we can give back, thats what our stance is, Dimitri said. Thats what we want to do.

See the original post:
Jordan softball donates funds to American Cancer Society – Columbus Ledger-Enquirer

Posted in Cancer Causes | Comments Off on Jordan softball donates funds to American Cancer Society – Columbus Ledger-Enquirer

4 Secret Signs Of Ovarian Cancer (Check Urine Now) – The Alternative Daily (blog)

Posted: August 16, 2017 at 3:43 pm

To date, cancer is the leading cause of death throughout the world. In fact, it is to blame for more than 30 percent of all deaths in Canada, which is more than any other disease. Estimates by the Canadian and American Cancer Societies say that ovarian cancer had 2,800 new cases and 1,750 deaths in Canada, and 22,280 new cases and 14,240 deaths in the United States just in 2016.

Ovarian cancer develops when ovary cells form tumors that become malignant. It is often referred to as the silent killer since it shows little or no symptoms. In fact, it is quite difficult to detect during screening. While it is most common in post-menopausal women, ovarian cancer has recently started affecting women in their 30s and 40s. And according to the latest research, early cancer detection increases the chances of survival, so regular check-ins are a must.

Unfortunately, there isnt any reliable test at this time. The CA125 blood tests may give false negatives and, sadly, smear tests are not capable of picking up malignant cells. And there is yet another problem, as well. Many of the symptoms are often mistaken for markers of other diseases, such as irritable bowel syndrome (IBS). As a consequence, the ovarian tumor gets diagnosed at stage 3, when it is far too late.

Frequent stomach bloating that goes on for more than two or three weeks could indicate a cancerous tumor growth in the ovaries.

Pain from menstrual cramps or pain during menstruation are perfectly normal. However, persistent pain that lasts for several weeks could be a sign of ovarian cancer. Women who are pre-menopausal should be especially careful, since these symptoms are too often passed off as just period pain.

A decrease in appetite that seems to come out of the blue and lasts for several weeks could be a sign of several ailments. Stomach, intestine and bowel issues are the most commonly diagnosed. However, a reduced appetite can be a sign of ovarian cancer as well, so make sure you consult your doctor if this happens to you.

If you find yourself visiting the toilet more often than usual, without any changes in your liquid intake, you may have the early stages of ovarian cancer. Or, if you experience an urgent need to pee and an inability to hold it in, this could be another sign as well.

Many of these symptoms can be easily mistaken for issues with the gastrointestinal tract. Therefore, if you experience any of them, it is critical to monitor their persistence and frequency. If the symptoms dont subside in a few weeks, consult your primary care physician and get checked as soon as you can.

Remember: monitoring our health and learning to recognize symptoms is the key to early detection and an increased chance of survival. Get to know your body!

The Alternative Daily

See the article here:
4 Secret Signs Of Ovarian Cancer (Check Urine Now) – The Alternative Daily (blog)

Posted in Ovarian Cancer | Comments Off on 4 Secret Signs Of Ovarian Cancer (Check Urine Now) – The Alternative Daily (blog)

OMF – Joan Janssen, 53, ovarian cancer, Sun Prairie, WI, with … – WEEI.com

Posted: at 3:43 pm

I let us introduce you to Joan Janssen Joan is from sun prairie Wisconsin. Op with hand with cancer. Yeah I’m an and heard her Stephanie Morsi. Clinical research at the US even I think she’s been the Susan Smith. Center for women’s cancers high so great to meet both of it’s terrific. So Joseph give us your story what happened here. Well 2000 tan I was just I was have a normal life Wednesday that. Swelling started in my abdomen which common symptom. What was later diagnosed with but I went the doctor went to. Follow up appointments took a couple of weeks. It and eventually was diagnosed with ovarian cancer. And they immediately did. Awful. Our removal of all my. Ovaries fallopian tubes. Ever everything including. My spleen my immense tiny. Appendix. And then they diagnosed with ovarian cancer stage EC. And my guess I think it if few months to a couple of months recover. And then they started chemotherapy. And I went up in Addis and I was treated with over 75. Treatments chemotherapy injections amount. Pollution over 750. Yeah it was period of about top four years and you had no sweeter now. I had a spleen so you’re immune system must be a little psyche I am apparently stronger than I look I really came through it pretty well. Yen. At the end of three to remission or re occurrences. The doctors in Athens. Today hit it demeanor if they told me that. There was a whole lot different in medicine with the types treatments that they yet there. And at that point my husband and I are bent too often talked to doctor this year and we asked so I told. I felt confident. That I would be able to get to trial hair so it was about three months after my treatments at Madison ended. They have a wake up call for Dana Farber and they said that there was no trial here’s. So explain that the clinical trial because as it is it to is it. Obviously the trolley and wanted to do the patients and write what they how to they’d explain its use the benefits that you could be from. I was really really lucky that we have brand within your drug development he gave me the term. Early on my kidneys that targeted therapies that’s Rick that target there side. Google to targeted therapies for ovarian cancer and myself keen to. About expletive is not ten or twelve locations across the country that I sent emails to it. Dana Farber was the one that handled things and it targeted therapy basically goes into your body and seeks out just. Just achievers and destroys them rather than. And I chemotherapy setting it destroys everything that’s asked early it can locate your fingernails your hair so that’s why there’s Alley you’re white sells everything is just. Q so you’re really left weakened risen targeted there. So how often that you coming out her treatment so for weaker hand picking out every 28 days for a year and then now. To understand you sort of treat this does hate come with me and check out the should you bring friends each and every kind of program for. Our team yeah came out the first treatment of this. Of the second round there these but he doesn’t come every time he’s not he’s not big trap he’s very Paul seats are hard for him to it and do. Com. He’s just exhausted by locket around the city cost cameras nightly invigorated you wanted to define it in here to the Dana Farber program they also have the unity is when you come out of Boston stay with a host me in the meantime all the great things that the department does. Those of like the little things maybe just don’t think about he’s okay medical there’ll time we’re only gonna stay. He set this up as well. No I found it acting are they have a little Berkshire that it found aunt so anybody here you have to decide to call right yet. I’m super Atlantic yet he has I was hooked up with the family. Surgeon at Brigham. Women’s hand surgeon Chris Sampson and his like me get them through it was within I was talking about three minutes of meeting each other meet it I discovered that leaderboard. The same day. While. Wow that’s meant to be there are concerns that I have many friends and me ask you tell how how was she doing. She’s fabulous she status John has been on two clinical trials and we’re we’re talking about like the sacrifice to travel across the country and how how she’s just embrace this and we have a resource specialist that you sought out. Options to make this work the first trial she was here monthly. This trial that you’re on now is a little more tedious and she’s actually. Had to relocate for a period of time she’s used the resource specialist in the host’s famous as well as hoped lives. But she’s she’s living witness and she’s embraced it and she’s. Perfect patient she has not missed a B I can tell you. So it’s good the whole span when he mentioned hopeful large. That was a lot until yeah hope lacks is located in Jamaica Plain and it’s got forty resident it’s. Was built by AstraZeneca aunt is on American cancer counselors forty patients overturn now they’re back and forth here at the clinics. Not all department asked the other. Sweeten the unit Newt grinch and in Houston COLT. Four years old two meters an anchor chair on on the last night. For us they know reminders who’s been going through a tough she is now. If they permit a well here later in life. Figures from Wisconsin so we gotta like you know you spending a lot of time in Boston now. I am sure in order to pack where does your leaders and lives on your Rogers. Yeah. Yeah pretty good answer but it’s a city of Israel yard. Well it’s a great story and you found hope that you found hope here with Dana Farber. When it did not look good so we wish you the best going forward you look terrific and thank people mr. Sherrod story we appreciate it thank you.

Read more from the original source:
OMF – Joan Janssen, 53, ovarian cancer, Sun Prairie, WI, with … – WEEI.com

Posted in Ovarian Cancer | Comments Off on OMF – Joan Janssen, 53, ovarian cancer, Sun Prairie, WI, with … – WEEI.com

Tom Brady on K&C opens up about 2016 season, playing while mom was battling cancer – WEEI.com (blog)

Posted: at 3:42 pm

Tom Brady called intoKirk & Callahan to kickoff the 2017 WEEI/NESN Jimmy Fund Radio Telethon on Tuesday morning. The quarterback went in-depth on last season and what it was like playing while his mom, Galynn, was going through cancer treatments across the country. For the complete interview, visit the Jimmy Fund Radio-Telethon audio on demand page.

Brady spoke about how he did what he could while being in New England when his parents were in California and how he had extra motivation to get to Super Bowl LI.

It was a very challenging time for our family,” Brady said. “My mom has been such an important, loving, caring, sweet, kind, generous mom. You want to be able to be there for her in moments like that. You just do the best you can do from afar. Obviously, playing football, it is hard to do that because there is a commitment to a team that needs you also. I knew my dad was taking good care of her and like I said leading up to the Super Bowl, my dad had only been to one game all season. They hadnt been at any of those games over the course of the year together, which was the first time in my entire playing career. It was really special when she was at the Super Bowl. Really special to celebrate with her and she was really looking forward to going to the Super Bowl. I wanted her to be there and I wanted our team to get there.

“Fortunately, we were able to get there. It was a really special time for our family. We have such great memories being there together. Its great it turned out the way it did because it really her treatments were ending at that point. It kind of signified not only the end of the season, but what she was going through, what our family was going through. It was a great way to end the year.

The quarterback said not only was it his dad there every step of the way, but his sisters and family friends. Everyone wanted to contribute and help, which helped him knowing his mom was in good care.

My mom going through it, but my dad was right there along side every step of the way,” he said.”I am on the other coast, so I wasnt there on a daily basis. I could only offer certain kinds of support in certain ways from afar. A lot of it was happening during the football season and my sisters were there every day bringing my mom to her appointments and her treatments, really providing different kinds of support and care that she needed. My dad was there every step of the way. My moms friends and my dads friends, everyone. Everyone wants to contribute and help in anyway they can.

“Youre always trying to figure out ways you can help and for me as an individual, you just do the best you can do. Certainly, to see my mom now and come through it, I think she has a different perspective, too. You never know what happens in this life and I think we appreciate all these days that we have and all these moments with each other. Thats really what I have tried to focus on.

Brady said Galynnis doing well now and not only surprised him at training camp practice last week, but his wife Gisele Bundchen threw him a surprise birthday party last Saturday and she was there too, when Brady thought his parents had already left town.

Shes doing really well, thanks for asking,” Brady said.”She couldnt be any better considering everything shes gone through. Everyone in our family is so happy. She got some tests back that were really positive and shes on the road to recovery. Were all very happy about that.

The quarterback usually is part of Patriots Monday, but his appearance was pushed back a day so he could be part of the telethon

Cancer is such a part of everyones life, unfortunately,” he said.”It hits everyone at some point and is in everyones family. Its great that people are continuing to create awareness and trying to find ways to create better solutions and cures and really help people who are in need. Obviously, with my mom and my family, its been something weve had to deal with and just a terrible disease. I am happy I am able to participate today and hopefully we can raise a lot of money.”

Read more here:
Tom Brady on K&C opens up about 2016 season, playing while mom was battling cancer – WEEI.com (blog)

Posted in Cancer Cures | Comments Off on Tom Brady on K&C opens up about 2016 season, playing while mom was battling cancer – WEEI.com (blog)

Nine reasons to become a Champion of Hope during PCH Give-A-Thon – KTAR.com

Posted: at 3:42 pm

Posted in Cancer Cures | Comments Off on Nine reasons to become a Champion of Hope during PCH Give-A-Thon – KTAR.com

Page 10«..9101112..2030..»